The current data demonstrated that in addition to suppression of the IRE1α branch of JNK signaling, melatonin supplementation prevented glomerulosclerosis, glomerular hypertrophy, and tubulointerstitial damage, which are common features seen in patients with obesity and T2DM [64,65]. The gene discussed is ERN1; the disease is obesity disorder.